Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response

Background: Few studies have provided real-world evidence of mepolizumab efficacy and safety. We aimed to evaluate mepolizumab for severe eosinophilic asthma in daily clinical practice. Research design and methods: Patients included in the RINOVA (Interdisciplinary Network for the management of seve...

Full description

Bibliographic Details

Published in:	Expert review of respiratory medicine Vol. 13; no. 12; pp. 1205 - 1212
Main Authors:	Caminati, Marco, Cegolon, Luca, Vianello, Andrea, Chieco Bianchi, Fulvia, Festi, Giuliana, Marchi, Maria R, Micheletto, Claudio, Mazza, Francesco, Tognella, Silvia, Senna, Gianenrico
Format:	Journal Article
Language:	English
Published:	England Taylor & Francis 02.12.2019
Subjects:	asthma network eosinophils mepolizumab real-world evidence Severe asthma eosinophils real-world evidence Severe asthma mepolizumab asthma network
ISSN:	1747-6348, 1747-6356, 1747-6356
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!